Representation of Multi‐Target Activity Landscapes Through Target Pair‐Based Compound Encoding in Self‐Organizing Maps
暂无分享,去创建一个
[1] José L. Medina-Franco,et al. Consensus Models of Activity Landscapes with Multiple Chemical, Conformer, and Property Representations , 2011, J. Chem. Inf. Model..
[2] Anne Mai Wassermann,et al. Design of Multitarget Activity Landscapes That Capture Hierarchical Activity Cliff Distributions , 2011, J. Chem. Inf. Model..
[3] J. Bajorath. Computational analysis of ligand relationships within target families. , 2008, Current opinion in chemical biology.
[4] Jürgen Bajorath,et al. Comprehensive Analysis of Single‐ and Multi‐Target Activity Cliffs Formed by Currently Available Bioactive Compounds , 2011, Chemical biology & drug design.
[5] J. Mestres,et al. Conciliating binding efficiency and polypharmacology. , 2009, Trends in pharmacological sciences.
[6] J. Bajorath,et al. Activity landscape representations for structure-activity relationship analysis. , 2010, Journal of medicinal chemistry.
[7] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[8] Rajarshi Guha,et al. Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs , 2008, J. Chem. Inf. Model..
[9] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[10] Jürgen Bajorath,et al. Rationalizing Three-Dimensional Activity Landscapes and the Influence of Molecular Representations on Landscape Topology and the Formation of Activity Cliffs , 2010, J. Chem. Inf. Model..
[11] Mathias Wawer,et al. Navigating structure-activity landscapes. , 2009, Drug discovery today.
[12] Jürgen Bajorath,et al. From Structure–Activity to Structure–Selectivity Relationships: Quantitative Assessment, Selectivity Cliffs, and Key Compounds , 2009, ChemMedChem.
[13] Anne Mai Wassermann,et al. Computational Analysis of Multi‐target Structure–Activity Relationships to Derive Preference Orders for Chemical Modifications toward Target Selectivity , 2010, ChemMedChem.
[14] Wendy A. Warr,et al. ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI) , 2009, J. Comput. Aided Mol. Des..
[15] Johann Gasteiger,et al. Neural networks in chemistry and drug design , 1999 .
[16] Jürgen Bajorath,et al. Design of multi-target activity landscapes that capture hierarchical activity cliff distributions , 2012, Journal of Cheminformatics.
[17] J. Bajorath,et al. Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. , 2008, Journal of medicinal chemistry.
[18] Michael J. Keiser,et al. The Chemical Basis of Pharmacology , 2010, Biochemistry.
[19] John P. Overington. ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr. , 2009, Journal of computer-aided molecular design.
[20] José L. Medina-Franco,et al. Structure–activity relationships of benzimidazole derivatives as antiparasitic agents: Dual activity-difference (DAD) maps , 2011 .
[21] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.